
Vaccine Vials Market Outlook - Forecast Trends, Market Size, Share and Growth Analysis Report (2025-2034)
Description
The global vaccine vials market attained a value of USD 22.56 Billion in 2024 . The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 6.70% , to reach USD 43.15 Billion by 2034 .
Global Vaccine Vials Market Overview
Vaccines help to protect the body from various illnesses, particularly bacterial and viral infectious/non-infectious diseases. They are stored in cylindrical units called vaccine vials. The rise in infectious diseases has fuelled the production of vaccines. In 2023, around 64 infectious diseases were reported to affect individuals spanning across 235 countries. The surge in vaccine production to combat infectious diseases and other medical conditions has led to an increased vaccine vials market demand.
The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023 , SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.
The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.
Global Vaccine Vials Market Segmentation
Vaccine Vials Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Material
Market Breakup by Capacity
Market Breakup by Application
Market Breakup by Region
Global Vaccine Vials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Key Queries Solved in the Global Vaccine Vials Market Report
Global Vaccine Vials Market Overview
Vaccines help to protect the body from various illnesses, particularly bacterial and viral infectious/non-infectious diseases. They are stored in cylindrical units called vaccine vials. The rise in infectious diseases has fuelled the production of vaccines. In 2023, around 64 infectious diseases were reported to affect individuals spanning across 235 countries. The surge in vaccine production to combat infectious diseases and other medical conditions has led to an increased vaccine vials market demand.
The increased investment in the research and development of vaccines is also bolstering the market growth for vaccine vials. In April 2023 , SK Bioscience, a vaccine development company based in South Korea, announced its plan to invest USD 1.8 billion in its vaccine and contract development and manufacturing organization (CDMO) businesses. They intend for strategic mergers and acquisitions initiatives in the vaccine domain, among others. With half of the investment reserved for vaccine development, the company plans to develop 5 more vaccine pipelines.
The vaccine vials market growth is also driven by the growing awareness among patients about immunization and its benefits. The rising healthcare expenditure to improve patient outcomes is another factor that will aid in the expansion of the market size.
Global Vaccine Vials Market Segmentation
Vaccine Vials Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Single Dose
- Multiple Dose
Market Breakup by Material
- Glass
- Polymer
Market Breakup by Capacity
- 10 ml
- 20 ml
- 5 ml
- 3ml
- 2ml
Market Breakup by Application
- Preventive Vaccine
- Therapeutics Vaccine
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Vaccine Vials Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cardinal Health Inc.
- Nipro Corporation
- Thermo Fisher Scientific Inc.
- Zebra Technologies Corporation,
- Schott AG,
- Gerresheimer AG
- Lisaline Lifescience Technologies Pvt Ltd.
- DWK Life Sciences GmbH
- Catalent, Inc.,
- EVIGENCE SENSORS Inc.,
- Richland Glass Company Inc.
- Vetter Pharma
- Pacific Vial Manufacturing Inc.,
- Berlin Material Type LLC
- Stevanato Group
Key Queries Solved in the Global Vaccine Vials Market Report
- How will the market landscape evolve in the coming years?
- What are the key market trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- Which country is poised to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What types of vaccine vials are available in the market?
- Which vaccine vial material is expected to dominate the respective market segment?
- Which key market players are projected to influence the market?
- What are the key research initiatives expected to boost the vaccine vials market share during the forecast period?
- What technological advancements and innovations are influencing vaccine vial design, materials, and manufacturing processes?
- Which segment has the most major impact on the market size?
- How did the COVID-19 pandemic affected the vaccine vials market?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics?
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Vaccine Vials Market Overview
- 3.1 Global Vaccine Vials Market Historical Value (2018-2024)
- 3.2 Global Vaccine Vials Market Forecast Value (2025-2034)
- 4 Global Vaccine Vials Market Landscape*
- 4.1 Global Cardiac Pacemaker: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Cardiac Pacemaker: Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Material
- 4.2.3 Analysis by Capacity
- 4.2.4 Analysis by Application
- 5 Global Vaccine Vials Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Vaccine Vials Market Segmentation (218-2034)
- 6.1 Global Vaccine Vials Market (2018-2034) by Type
- 6.1.1 Market Overview
- 6.1.2 Single Dose
- 6.1.3 Multiple Dose
- 6.2 Global Vaccine Vials Market (2018-2034) by Material
- 6.2.1 Market Overview
- 6.2.2 Glass
- 6.2.3 Polymer
- 6.3 Others Global Vaccine Vials Market (2018-2034) by Capacity
- 6.3.1 Market Overview
- 6.3.2 10 ml
- 6.3.3 20 ml
- 6.3.4 5 ml
- 6.3.5 3ml
- 6.3.6 2ml
- 6.4 Global Vaccine Vials Market (2018-2034) by Application
- 6.4.1 Market Overview
- 6.4.2 Preventive Vaccine
- 6.4.3 Therapeutics Vaccine
- 6.5 Global Vaccine Vials Market (2018-2034) by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Sterility testing market (218-2034)
- 7.1 North America Sterility testing market (2018-2034) by Type
- 7.1.1 Market Overview
- 7.1.2 Single Dose
- 7.1.3 Multiple Dose
- 7.2 North America Sterility testing market (2018-2034) by Material
- 7.2.1 Market Overview
- 7.2.2 Glass
- 7.2.3 Polymer
- 7.3 North America Sterility testing market (2018-2034) by Country
- 7.3.1 United States of America
- 7.3.2 Canada
- 8 Europe Sterility testing market (218-2034)
- 8.1 Europe Sterility testing market (2018-2034) by Type
- 8.1.1 Market Overview
- 8.1.2 Single Dose
- 8.1.3 Multiple Dose
- 8.2 Europe Sterility testing market (2018-2034) by Material
- 8.2.1 Market Overview
- 8.2.2 Glass
- 8.2.3 Polymer
- 8.3 Europe Sterility testing market (2018-2034) by Country
- 8.3.1 United Kingdom
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Others
- 9 Asia Pacific Sterility testing market (218-2034)
- 9.1 Asia Pacific Sterility testing market (2018-2034) by Type
- 9.1.1 Market Overview
- 9.1.2 Single Dose
- 9.1.3 Multiple Dose
- 9.2 Asia Pacific Sterility testing market (2018-2034) by Material
- 9.2.1 Market Overview
- 9.2.2 Glass
- 9.2.3 Polymer
- 9.3 Asia Pacific Sterility testing market (2018-2034) by Country
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 ASEAN
- 9.3.5 Australia
- 9.3.6 Others
- 10 Latin America Sterility testing market (218-2034)
- 10.1 Latin America Sterility testing market (2018-2034) by Type
- 10.1.1 Market Overview
- 10.1.2 Single Dose
- 10.1.3 Multiple Dose
- 10.2 Latin America Sterility testing market (2018-2034) by Material
- 10.2.1 Market Overview
- 10.2.2 Glass
- 10.2.3 Polymer
- 10.3 Latin America Sterility testing market (2018-2034) by Country
- 10.3.1 Brazil
- 10.3.2 Argentina
- 10.3.3 Mexico
- 10.3.4 Others
- 11 Middle East and Africa Sterility testing market (218-2034)
- 11.1 Middle East and Africa Sterility testing market (2018-2034) by Type
- 11.1.1 Market Overview
- 11.1.2 Single Dose
- 11.1.3 Multiple Dose
- 11.2 Middle East and Africa Sterility testing market (2018-2034) by Material
- 11.2.1 Market Overview
- 11.2.2 Glass
- 11.2.3 Polymer
- 11.3 Middle East and Africa Sterility testing market (2018-2034) by Country
- 11.3.1 Saudi Arabia
- 11.3.2 United Arab Emirates
- 11.3.3 Nigeria
- 11.3.4 South Africa
- 11.3.5 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Type
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Cardinal Health Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Nipro Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Thermo Fisher Scientific Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Zebra Technologies Corporation,
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Schott AG,
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Gerresheimer AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Lisaline Lifescience Technologies Pvt Ltd.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 DWK Life Sciences GmbH
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Catalent, Inc.,
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 EVIGENCE SENSORS Inc.,
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Richland Glass Company Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Vetter Pharma
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Pacific Vial Manufacturing Inc.,
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Berlin Material Type LLC
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Stevanato Group,
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.